Kathmere Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Kathmere Capital Management's BMY Position: Q3 2026 in Review
Kathmere Capital Management increased its Bristol-Myers Squibb (BMY) stake by 73% in Q3 2026, buying an estimated $1.72M and bringing the position to 64,466 shares worth $4.02M. The position accounts for 0.19% of the portfolio, ranked #94.
Kathmere Capital Management first reported a position in BMY in Q4 2019 and has held it in 16 quarters since. 2,569 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Kathmere Capital Management held 64,466 shares of Bristol-Myers Squibb worth $4.02M as of Q3 2026.
- Kathmere Capital Management bought 27,269 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.72M.
- Bristol-Myers Squibb made up 0.19% of Kathmere Capital Management's portfolio in Q3 2026, its #94 holding.
- Kathmere Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 16 quarters since.
- 2,569 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Kathmere Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.